Binosto is a medication that is used for treating osteoporosis in postmenopausal women and increasing bone mass in men who have osteoporosis. This prescription medicine comes as an effervescent tablet that is dissolved in water and swallowed once a week. There is only one standard dosage of this drug. Potential side effects include heartburn, nausea, and abdominal (stomach) pain.
What Is Binosto?
Binosto™ (alendronate effervescent tablet) is a prescription medication approved for the following uses:
- Treating osteoporosis in postmenopausal women
- Increasing bone mass in men with osteoporosis.
Binosto contains the same active ingredient as Fosamax® (alendronate), but is an effervescent tablet that dissolves in water. This makes the drug a good choice for people who have difficulty swallowing pills. It belongs to a group of medicines known as bisphosphonates.
Who Makes This Medication?
This medication is made by SwissCo Services AG for Mission Pharmacal Company.
How Does Binosto Work?
Healthy bones go through a natural cycle of turnover in which they are continuously broken down (a process called resorption) and rebuilt (a process called formation). Binosto binds to certain parts of the bone and blocks the activity of cells called osteoclasts that are responsible for breaking bone down. This helps slow down the rate of bone breakdown, which can increase bone density.